Adem, S.; Eyupoglu, V.; Sarfraz, I.; Rasul, A.; Ali, M. 2020. Identification of Potent COVID–19 Main Protease (Mpro) Inhibitors from Natural Polyphenols: An in Silico Strategy Unveils a Hope against CORONA. Preprints, 2020030333.
Aggarwal, M., Leser, G and Lamb, R. 2020. Repurposing papaverine as an antiviral agent against influenza viruses and paramyxoviruses. Journal of Virology. 94(6), e01888–19.
Alamri, M. A.; Tahir ul Qamar, M.; Alqahtani, S. M. 2020. Pharmacoinformatics and Molecular Dynamic Simulation Studies Reveal Potential Inhibitors of SARS-CoV–2 Main Protease 3CLpro. Preprints, 2020020308.
Arsianti, A., Bahtiar, A., Fadilah, F., Wangsaputra, V., Paramita, R., Azizah, N and Kakiuchi, K. 2020. Synthesis, haracterization, and cytotoxicity evaluation of gallic acid nanoparticles towards breast T47D cancer cells. Pharmacognosy Journal, 12(2).
Bzowka, M., Mitusinska, K., Raczynska, A., Samol, A., Tuszynski, J. A., and Gora, A. 2020. Molecular Dynamics Simulations Indicate the COVID–19 Mpro Is Not a Viable Target for Small-Molecule Inhibitors Design. bioRxiv.
Bansal, A., Jan, I and Sharma, N. 2020. Anti-phytoviral activity of carvacrol vis-a-vis cauliflower mosaic virus (CaMV). Proceedings of the national academy of sciences, India section B: Biological Sciences, 1–8.
Capparelli, E., Holland, D., Okamoto, C., Gragg, B., Durelle, J., Marquie-Beck, J and HNRC Group. 2005. Lopinavir concentrations in cerebrospinal fluid exceed the 50% inhibitory concentration for HIV. Aids, 19(9), 949–952.
Chandel, V.; Raj, S.; Rathi, B.; Kumar, D. 2020. In Silico Identification of Potent COVID–19 Main Protease Inhibitors from FDA Approved Antiviral Compounds and Active Phytochemicals through Molecular Docking: A Drug Repurposing Approach. Preprints, 2020030349.
Bhal, S. 2007. LogP—Making sense of the value. Advanced chemistry development, Toronto, ON, Canada, 1–4.
Bonfim, C., Monteleoni, L., Calmon, M., Cândido, N., Provazzi, P., Lino, V and Melli, P. 2020. Antiviral activity of curcumin-nanoemulsion associated with photodynamic therapy in vulvar cell lines transducing different variants of HPV–16. Artificial Cells, Nanomedicine, and Biotechnology, 48(1), 515–524.
Chandani, S., Thorat, P., Nanda, R and Chitlange, S. 2019. Docking of phytoconstituents of Cynodon dactylon on NS2B NS3 protease domain of dengue virus. Research Journal of Pharmacy and Technology, 12(12), 5865–5870.
Chang, Y., Tung, Y., Lee, K., Chen, T., Hsiao, Y., Chang, H and Shih, S. 2020. Potential therapeutic agents for COVID–19 based on the analysis of protease and RNA polymerase docking. preprints.org.
Cheminformatics, M. 2020. Molinspiration. Web-enabled software for large-scale calculation of molecular properties and database searches, Free online molecular descriptor calculations.
Contini, A. 2020. Virtual screening of an FDA approved drugs database on two COVID–19 coronavirus proteins. chemrxiv.org.
Corona, A., Onnis, V., Del Vecchio, C., Esposito, F., Cheng, Y and Tramontano, E. 2020. 2-(Arylamino)–6-(trifluoromethyl) nicotinic acid derivatives: New HIV–1 RT dual inhibitors active on viral replication. Molecules, 25(6), 1338.
Del Bosco, S., Abbate, L., Mercati, F., Napoli, E and Ruberto, G. 2020. Essential oils in citrus. In the Citrus Genome (pp. 211–223). Springer, Cham.
Devaux, C., Rolain, J., Colson, P and Raoult, D. 2020. New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID–19?. International Journal of Antimicrobial Agents, 105938.
Dos Santos, K., Guedes, I., Karl, A and Dardenne, L. 2020. Highly flexible ligand docking: Benchmarking of the DockThor program on the LEADS-PEP protein-peptide dataset. Journal of Chemical Information and Modeling. 60(2), 667–683
Gautret, P., Lagier, J., Parola, P., Meddeb, L., Mailhe, M., Doudier, B and Honoré, S. 2020. Hydroxychloroquine and azithromycin as a treatment of COVID–19: results of an open-label non-randomized clinical trial. International Journal of Antimicrobial Agents, 105949.
Gentile, D.; Patamia, V.; Scala, A.; Sciortino, M. T.; Piperno, A.; Rescifina, A. 2020. Inhibitors of SARS-CoV–2 Main Protease from a Library of Marine Natural Products: A Virtual Screening and Molecular Modeling Study. Preprints, 2020030372.
Gomez, D., Huber, K and Klumpp, S. 2019. On protein folding in crowded conditions. The Journal of Physical Chemistry Letters, 10(24), 7650–7656.
Izgelov, D., Domb, A. J., and Hoffman, A. 2020. The Effect of Piperine on Oral Absorption of Cannabidiol following Acute vs. Chronic Administration. European Journal of Pharmaceutical Sciences, 105313.
Jiang, F., Deng, L., Zhang, L., Cai, Y., Cheung, C and Xia, Z. 2020. Review of the clinical characteristics of coronavirus disease 2019 (COVID–19). Journal of General Internal Medicine, 1–5.
Khaerunnisa, S.; Kurniawan, H.; Awaluddin, R.; Suhartati, S.; Soetjipto, S. 2020. Potential Inhibitor of COVID–19 Main Protease (Mpro) From Several Medicinal Plant Compounds by Molecular Docking Study. Preprints, 2020030226.
Kaisari, E and Borruat, F. 2020. Keeping an Eye on Hydroxychloroquine Retinopathy. Klinische Monatsblätter für Augenheilkunde. Efirst.
Kasahara, K., Ma, B., Goto, K., Dasgupta, B., Higo, J., Fukuda, I and Nakamura, H. 2016. myPresto/omegagene: a GPU-accelerated molecular dynamics simulator tailored for enhanced conformational sampling methods with a non-Ewald electrostatic scheme. Biophysics and Physicobiology, 13, 209–216.
Lee, C., Cho, A. Y., Yoon, W., Yun, H., Kang, J and Lee, J. 2019. Co-crystal formation via resorcinol–urea interactions: Naringenin and carbamazepine. Crystal growth & design, 19(7), 3807–3814.
Liu, X., Zhang, B., Jin, Z., Yang, H and Rao, Z. 2020. The crystal structure of 2019-NCoV main protease in complex with an inhibitor N3. RCSB Protein Data Bank.
Lopes, B., da Costa, M., Ribeiro, A., da Silva, T., Lima, C., Caruso, I and Desideri, A. 2020. Quercetin pentaacetate inhibits in vitro human respiratory syncytial virus adhesion. Virus Research, 276, 197805.
Mishra, S., Pandey, A and Manvati, S. 2020. Coumarin: An emerging antiviral agent. Heliyon, 6(1), e03217.
Mohammad, F., Mohsin, A., Zaw, A., Tanveer, A., Waseem, A. 2020. Identification of Dietary Molecules as Therapeutic Agents to Combat COVID–19 Using Molecular Docking Studies, PREPRINT (Version 1) available at Research Square.
Narayanaswamy, R and Esa, N. 2018. Phytic acid (myo-inositol hexaphosphate)-a promising pharmaceutical agent: a review. Asian Journal of Pharmaceutical and Clinical Research, 11(11), 42–46.
Nile, S., Kim, D., Nile, A., Park, G., Gansukh, E and Kai, G. 2020. Probing the effect of quercetin 3-glucoside from Dianthus superbus L against influenza virus infection-In vitro and in silico biochemical and toxicological screening. Food and Chemical Toxicology, 135, 110985.
Patra, J., Das, G., Bose, S., Banerjee, S., Vishnuprasad, C., del Pilar Rodriguez, M and Shin, H. 2020. Star anise (Illicium verum):: Chemical compounds, antiviral properties, and clinical relevance. Phytotherapy Research. 1–20.
Plowe, C. 2005. Antimalarial drug resistance in Africa: strategies for monitoring and deterrence. In Malaria: drugs, disease and post-genomic biology (pp. 55–79). Springer, Berlin, Heidelberg.
Reena Roy, D., Kandagalla, S and Krishnappa, M. 2020. Exploring the ethnomycological potential of Lentinus squarrosulus Mont. through GC–MS and chemoinformatics tools. Mycology, 11(1), 78.
Savarino, A., Lucia, M., Giordano, F and Cauda, R. 2006. Risks and benefits of chloroquine use in anticancer strategies. The Lancet. Oncology, 7(10), 792–793.
Sharma, A.D.; Kaur, I. 2020. Eucalyptol (1,8 cineole) from Eucalyptus Essential Oil a Potential Inhibitor of COVID 19 Corona Virus Infection by Molecular Docking Studies. Preprints 2020030455.
Shayeganmehr, A., Vasfi Marandi, M., Karimi, V., Barin, A and Ghalyanchilangeroudi, A. 2018. Zataria multiflora essential oil reduces replication rate of avian influenza virus (H9N2 subtype) in challenged broiler chicks. British Poultry Science, 59(4), 389–395.
Silva, A., Bento, C., Pena, A., Figueiredo, L., Prudêncio, C., Aguiar, L and Gomes, P. 2020. Cinnamic acid conjugates in the rescuing and repurposing of classical antimalarial drugs. Molecules, 25(1), 66.
Sotelo, J., Briceno, E and López-González, M. 2006. Adding chloroquine to conventional treatment for glioblastoma multiforme: a randomized, double-blind, placebo-controlled trial. Annals of Internal Medicine, 144(5), 337–343.
Sun, Y., Yang, A. W and Lenon, G. 2020. Phytochemistry, ethnopharmacology, pharmacokinetics and toxicology of Cnidium monnieri (L.) Cusson. International Journal of Molecular Sciences, 21(3), 1006.
Sun, N.; Wong, W.; Guo, J. 2020. Prediction of Potential 3CLpro-Targeting Anti-SARS-CoV–2 Compounds from Chinese Medicine. Preprints, 2020030247.
Tang, K., Zhang, X and Guo, Y. 2020. Identification of the dietary supplement capsaicin as an inhibitor of Lassa virus entry. Acta Pharmaceutica Sinica B.
Thomsen, R and Christensen, M. 2006. MolDock: a new technique for high-accuracy molecular docking. Journal of Medicinal Chemistry, 49(11), 3315–3321.
Uhlemann, A and Krishna, S. 2005. Antimalarial multi-drug resistance in Asia: mechanisms and assessment. In malaria: drugs, disease and post-genomic Biology (pp. 39–53). Springer, Berlin, Heidelberg.
Qamar, M., Alqahtani, S., Alamri, M and Chen, L. 2020. Structural basis of SARS-CoV–2 3CLpro and anti-COVID–19 drug discovery from medicinal plants. preprints.org.
Wang, J. 2020. Fast Identification of possible drug treatment of coronavirus disease–19 (COVID–19) through computational drug repurposing study. chemrxiv.org.
Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M and Xiao, G. 2020. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Research, 30(3), 269–271.
Wang, B., Guo, H., Ling, L., Ji, J., Niu, J and Gu, Y. 2020. The Chronic Adverse Effect of Chloroquine on Kidney in Rats through an Autophagy Dependent and Independent Pathways. Nephron, 144(1), 53–64.
Wei, H., Wang, J., Cheng, C., Jin, L and Peng, J. 2020. Application of plant essential oils in pig diets. In feed additives (pp. 227–237). Academic press.
Xie, Y., Chen, Y., Guo, Y., Huang, Y and Zhu, B. 2020. Allicin and glycyrrhizic acid display antiviral activity against latent and lytic Kaposi’s sarcoma-associated herpesvirus. Infectious Microbes & Diseases.
Xu, X., Chen, P., Wang, J., Feng, J., Zhou, H., Li, X and Hao, P. 2020. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Science China Life Sciences, 63(3), 457–460.